9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          This study identifies a mechanism by which 17β estradiol (estrogen) contributes to peripheral tolerance via modulation of regulatory T cell (Treg) differentiation and function. Our results show that estrogen signaling through the nuclear receptor ERβ is required for TGF-β–dependent differentiation of Tregs, a critical pathway for peripheral Treg differentiation in the gut. Female patients with Crohn’s disease express significantly lower levels of ERβ in peripheral T cells and the intestinal mucosae. Tregs deficient in ERβ express aberrant levels of Tsc22d3 (GILZ), a protein not normally expressed in Tregs and that interferes with functional Treg suppression. Our findings support a pathway by which ERβ-specific signaling normally functions to limit GILZ expression in Tregs, thus maintaining peripheral tolerance in the gut.

          Abstract

          Signaling of 17β-estradiol (estrogen) through its two nuclear receptors, α and β (ERα, ERβ), is an important mechanism of transcriptional regulation. Although ERs are broadly expressed by cells of the immune system, the mechanisms by which they modulate immune responses remain poorly understood. ERβ-specific signaling is reduced in patients with chronic inflammatory diseases, including systemic lupus erythematosus and inflammatory bowel disease, and our previous work suggests that dysregulation of ERβ-specific signaling contributes to enhanced intestinal inflammation in female SAMP/YitFC mice, a spontaneous model of Crohn’s disease-like ileitis. The present study builds on these prior observations to identify a nonredundant, immunoprotective role for ERβ-specific signaling in TGF-β–dependent regulatory T cell (Treg) differentiation. Using a strain of congenic SAMP mice engineered to lack global expression of ERβ, we observed dramatic, female-specific exacerbation of intestinal inflammation accompanied by significant reductions in intestinal Treg frequency and function. Impaired Treg suppression in the absence of ERβ was associated with aberrant overexpression of Tsc22d3 (GILZ), a glucocorticoid-responsive transcription factor not normally expressed in mature Tregs, and ex vivo data reveal that forced overexpression of GILZ in mature Tregs inhibits their suppressive function. Collectively, our findings identify a pathway of estrogen-mediated immune regulation in the intestine, whereby homeostatic expression of ERβ normally functions to limit Treg-specific expression of GILZ, thereby maintaining effective immune suppression. Our data suggest that transcriptional cross-talk between glucocorticoid and steroid sex hormone signaling represents an important and understudied regulatory node in chronic inflammatory disease.

          Related collections

          Author and article information

          Journal
          Proc Natl Acad Sci U S A
          Proc. Natl. Acad. Sci. U.S.A
          pnas
          pnas
          PNAS
          Proceedings of the National Academy of Sciences of the United States of America
          National Academy of Sciences
          0027-8424
          1091-6490
          21 July 2020
          6 July 2020
          : 117
          : 29
          : 17166-17176
          Affiliations
          [1] aDepartment of Pathology, Case Western Reserve University School of Medicine , Cleveland, OH 44106;
          [2] bDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine , Cleveland, OH 44106
          Author notes
          1To whom correspondence may be addressed. Email: wag@ 123456case.edu or theresa.pizarro@ 123456case.edu .

          Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved June 8, 2020 (received for review February 6, 2020)

          Author contributions: W.A.G. and T.T.P. designed research; W.A.G., S.M.B., and H.L.H. performed research; W.A.G., S.M.B., B.R., and M.J.C. analyzed data; and W.A.G. wrote the paper.

          Author information
          https://orcid.org/0000-0002-6864-0384
          https://orcid.org/0000-0002-7332-9152
          https://orcid.org/0000-0003-4768-4094
          https://orcid.org/0000-0003-3163-915X
          Article
          PMC7382259 PMC7382259 7382259 202002266
          10.1073/pnas.2002266117
          7382259
          32632016
          7b81dd75-0ba4-4ea9-bbda-210d64465d6b
          Copyright @ 2020

          Published under the PNAS license.

          History
          Page count
          Pages: 11
          Funding
          Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100000062
          Award ID: K01 DK105138
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan Award Recipient : Theresa T Pizarro
          Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100000062
          Award ID: P01 DK091222
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan Award Recipient : Theresa T Pizarro
          Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100000062
          Award ID: P30 DK097948
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan Award Recipient : Theresa T Pizarro
          Funded by: Crohn's and Colitis Foundation of America (CCFA) 100001063
          Award ID: 329284
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan
          Funded by: Crohn's and Colitis Foundation of America (CCFA) 100001063
          Award ID: 635911
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan
          Funded by: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100000062
          Award ID: T35 DK111373
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan Award Recipient : Theresa T Pizarro
          Funded by: Crohn's and Colitis Foundation of America (CCFA) 100001063
          Award ID: 585026
          Award Recipient : Wendy A Goodman Award Recipient : Sarah M Bedoyan
          Categories
          Biological Sciences
          Immunology and Inflammation

          regulatory T cell,estrogen,inflammation,Crohn’s disease,inflammatory bowel disease

          Comments

          Comment on this article